| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 17,207 | 16,756 | 15,552 | 17,428 | | Cost of Revenue | 7,736 | 7,929 | 7,431 | 7,801 | | | Gross Profit | 9,471 | 8,827 | 8,120 | 9,627 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,630 | 7,497 | 7,094 | 8,420 | | Non Recurring | 10 | 13 | (7) | 22,348 | | Others | 350 | 257 | 200 | 212 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,481 | 1,060 | 833 | (21,353) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 4,481 | 1,060 | 833 | (21,353) | | Interest Expense | 649 | 652 | 683 | 710 | | Income Before Tax | 3,832 | 408 | 150 | (22,063) | | Income Tax Expense | 1,539 | 176 | 56 | (216) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,293 | 232 | 95 | (21,847) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,293 | 232 | 95 | (21,847) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,293 | $232 | $95 | ($21,847) |
|
0.03% Nasdaq 
Income Statement
